Literature DB >> 25832656

FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.

Ai-Hua Gong1, Ping Wei2, Sicong Zhang3, Jun Yao4, Ying Yuan5, Ai-Dong Zhou2, Frederick F Lang2, Amy B Heimberger2, Ganesh Rao2, Suyun Huang6.   

Abstract

The growth factor PDGF controls the development of glioblastoma (GBM), but its contribution to the function of GBM stem-like cells (GSC) has been little studied. Here, we report that the transcription factor FoxM1 promotes PDGFA-STAT3 signaling to drive GSC self-renewal and tumorigenicity. In GBM, we found a positive correlation between expression of FoxM1 and PDGF-A. In GSC and mouse neural stem cells, FoxM1 bound to the PDGF-A promoter to upregulate PDGF-A expression, acting to maintain the stem-like qualities of GSC in part through this mechanism. Analysis of the human cancer genomic database The Cancer Genome Atlas revealed that GBM expresses higher levels of STAT3, a PDGF-A effector signaling molecule, as compared with normal brain. FoxM1 regulated STAT3 transcription through interactions with the β-catenin/TCF4 complex. FoxM1 deficiency inhibited PDGF-A and STAT3 expression in neural stem cells and GSC, abolishing their stem-like and tumorigenic properties. Further mechanistic investigations defined a FoxM1-PDGFA-STAT3 feed-forward pathway that was sufficient to confer stem-like properties to glioma cells. Collectively, our findings showed how FoxM1 activates expression of PDGF-A and STAT3 in a pathway required to maintain the self-renewal and tumorigenicity of glioma stem-like cells. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832656      PMCID: PMC4452436          DOI: 10.1158/0008-5472.CAN-14-2800

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.

Authors:  Youngmi Kim; Eunhee Kim; Qiulian Wu; Olga Guryanova; Masahiro Hitomi; Justin D Lathia; David Serwanski; Andrew E Sloan; Robert J Weil; Jeongwu Lee; Akiko Nishiyama; Shideng Bao; Anita B Hjelmeland; Jeremy N Rich
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

2.  FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis.

Authors:  Nu Zhang; Ping Wei; Aihua Gong; Wen-Tai Chiu; Hsueh-Te Lee; Howard Colman; He Huang; Jianfei Xue; Mingguang Liu; Yong Wang; Raymond Sawaya; Keping Xie; W K Alfred Yung; René H Medema; Xi He; Suyun Huang
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

3.  The somatic genomic landscape of glioblastoma.

Authors:  Cameron W Brennan; Roel G W Verhaak; Aaron McKenna; Benito Campos; Houtan Noushmehr; Sofie R Salama; Siyuan Zheng; Debyani Chakravarty; J Zachary Sanborn; Samuel H Berman; Rameen Beroukhim; Brady Bernard; Chang-Jiun Wu; Giannicola Genovese; Ilya Shmulevich; Jill Barnholtz-Sloan; Lihua Zou; Rahulsimham Vegesna; Sachet A Shukla; Giovanni Ciriello; W K Yung; Wei Zhang; Carrie Sougnez; Tom Mikkelsen; Kenneth Aldape; Darell D Bigner; Erwin G Van Meir; Michael Prados; Andrew Sloan; Keith L Black; Jennifer Eschbacher; Gaetano Finocchiaro; William Friedman; David W Andrews; Abhijit Guha; Mary Iacocca; Brian P O'Neill; Greg Foltz; Jerome Myers; Daniel J Weisenberger; Robert Penny; Raju Kucherlapati; Charles M Perou; D Neil Hayes; Richard Gibbs; Marco Marra; Gordon B Mills; Eric Lander; Paul Spellman; Richard Wilson; Chris Sander; John Weinstein; Matthew Meyerson; Stacey Gabriel; Peter W Laird; David Haussler; Gad Getz; Lynda Chin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

4.  Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.

Authors:  Jianfei Xue; Xia Lin; Wen-Tai Chiu; Yao-Hui Chen; Guanzhen Yu; Mingguang Liu; Xin-Hua Feng; Raymond Sawaya; René H Medema; Mien-Chie Hung; Suyun Huang
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

5.  Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.

Authors:  Lin Cheng; Zhi Huang; Wenchao Zhou; Qiulian Wu; Shannon Donnola; James K Liu; Xiaoguang Fang; Andrew E Sloan; Yubin Mao; Justin D Lathia; Wang Min; Roger E McLendon; Jeremy N Rich; Shideng Bao
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

Review 6.  FOXM1: From cancer initiation to progression and treatment.

Authors:  Chuay-Yeng Koo; Kyle W Muir; Eric W-F Lam
Journal:  Biochim Biophys Acta       Date:  2011-09-29

7.  Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.

Authors:  Eunhee Kim; Misuk Kim; Dong-Hun Woo; Yongjae Shin; Jihye Shin; Nakho Chang; Young Taek Oh; Hong Kim; Jingeun Rheey; Ichiro Nakano; Cheolju Lee; Kyeung Min Joo; Jeremy N Rich; Do-Hyun Nam; Jeongwu Lee
Journal:  Cancer Cell       Date:  2013-05-16       Impact factor: 31.743

Review 8.  The role of Stat3 in glioblastoma multiforme.

Authors:  Rodney B Luwor; Stanley S Stylli; Andrew H Kaye
Journal:  J Clin Neurosci       Date:  2013-05-17       Impact factor: 1.961

9.  Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma.

Authors:  M Nistér; C H Heldin; B Westermark
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  41 in total

1.  Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.

Authors:  Mireia Náger; Maria Santacana; Deepshikha Bhardwaj; Joan Valls; Isidre Ferrer; Pere Nogués; Carles Cantí; Judit Herreros
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.

Authors:  Jianfei Xue; Aidong Zhou; Yamei Wu; Saint-Aaron Morris; Kangyu Lin; Samirkumar Amin; Roeland Verhaak; Gregory Fuller; Keping Xie; Amy B Heimberger; Suyun Huang
Journal:  Cancer Res       Date:  2016-05-31       Impact factor: 12.701

3.  Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFA/AKT-Signaling Axis.

Authors:  Guillermo C Rivera-Gonzalez; Brett A Shook; Johanna Andrae; Brandon Holtrup; Katherine Bollag; Christer Betsholtz; Matthew S Rodeheffer; Valerie Horsley
Journal:  Cell Stem Cell       Date:  2016-10-13       Impact factor: 24.633

4.  Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells.

Authors:  David L Schonberg; Tyler E Miller; Qiulian Wu; William A Flavahan; Nupur K Das; James S Hale; Christopher G Hubert; Stephen C Mack; Awad M Jarrar; Robert T Karl; Ann Mari Rosager; Anne M Nixon; Paul J Tesar; Petra Hamerlik; Bjarne W Kristensen; Craig Horbinski; James R Connor; Paul L Fox; Justin D Lathia; Jeremy N Rich
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

5.  Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.

Authors:  Dingyuan Luo; Magdalena Fraga-Lauhirat; Jonathan Millings; Cristella Ho; Emily M Villarreal; Teresa C Fletchinger; James V Bonfiglio; Leyda Mata; Matthew D Nemesure; Lauren E Bartels; Ruixue Wang; Basil Rigas; Gerardo G Mackenzie
Journal:  Carcinogenesis       Date:  2019-12-31       Impact factor: 4.944

6.  Messenger RNA Methylation Regulates Glioblastoma Tumorigenesis.

Authors:  Deobrat Dixit; Qi Xie; Jeremy N Rich; Jing Crystal Zhao
Journal:  Cancer Cell       Date:  2017-04-10       Impact factor: 31.743

7.  Notch1-STAT3-ETBR signaling in brain injury and cancer.

Authors:  Matthew D LeComte; Jeffrey L Spees
Journal:  Cytokine       Date:  2015-08-25       Impact factor: 3.861

8.  FOXM1 is a therapeutic target for high-risk multiple myeloma.

Authors:  C Gu; Y Yang; R Sompallae; H Xu; V S Tompkins; C Holman; D Hose; H Goldschmidt; G Tricot; F Zhan; S Janz
Journal:  Leukemia       Date:  2015-12-09       Impact factor: 11.528

9.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.

Authors:  Sicong Zhang; Boxuan Simen Zhao; Aidong Zhou; Kangyu Lin; Shaoping Zheng; Zhike Lu; Yaohui Chen; Erik P Sulman; Keping Xie; Oliver Bögler; Sadhan Majumder; Chuan He; Suyun Huang
Journal:  Cancer Cell       Date:  2017-03-23       Impact factor: 31.743

10.  Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities.

Authors:  Luciano Garofano; Simona Migliozzi; Young Taek Oh; Fulvio D'Angelo; Ryan D Najac; Aram Ko; Brulinda Frangaj; Francesca Pia Caruso; Kai Yu; Jinzhou Yuan; Wenting Zhao; Anna Luisa Di Stefano; Franck Bielle; Tao Jiang; Peter Sims; Mario L Suvà; Fuchou Tang; Xiao-Dong Su; Michele Ceccarelli; Marc Sanson; Anna Lasorella; Antonio Iavarone
Journal:  Nat Cancer       Date:  2021-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.